Fragmento

1. - Natriuretic peptides in ESRD 2.- Management of hypertension in patients with CKD: differences between primary and tertiary care settings. 3.-Cinacalcet hydrocloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. 4.-Mild hyperphosphatemia and mortality in hemodialysis patients. 5.- Systemic vasculitis: still a challengin disease. 6.-Performance of the Cockcroft-Gault and modification of diet in renal disease equation in estimating GFR in 111 hospitalized patients. 7.-Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ancas in crescentic glomerulonephritis 8.-The prevalence of ESRD treated with renal dialysis in France in 2003. 9.-Frequency of elevated serum aluminum levels in adult dialysis patients. 10.-Left ventricular hypertrophy in nondiabetic predialysis CKD. 11.-Epoietin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes. 12.-Cardiovascular risk and renal transplantation: post HOC analyses of the assessment of lescol in renal transplantation (ALERT) study. 13.-Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. PARA ESTA INFORMACIÓN, SUGERIMOS DESCARGAR FORMATO PDF.

Palabras clave:

2007-07-18   |   1,317 visitas   |   Evalua este artículo 0 valoraciones

Vol. 27 Núm.4. Octubre-Diciembre 2006 Pags. 144-148 Nefrol Mex 2006; 27(4)